Aurinia Pharmaceuticals (AUPH) Other Operating Expenses (2019 - 2026)
Aurinia Pharmaceuticals (AUPH) posted Other Operating Expenses of -$279000.0 for Q1 2026, down 105.5% on a QoQ basis from $5.1 million in Q4 2025, and up 93.7% year-over-year from -$144036.7 in Q1 2025.
Aurinia Pharmaceuticals (AUPH) Other Operating Expenses (2019 - 2026) Analysis & Trends
Aurinia Pharmaceuticals' Other Operating Expenses history runs 8 years deep, the most recent figure standing at -$279000.0 for Q1 2026.
- Quarterly Other Operating Expenses rose 93.7% year-over-year to -$279000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.4 million (down 27.88% YoY) and the FY2025 annual result came in at -$9.5 million, down 319.23% from the prior year.
- Other Operating Expenses was -$279000.0 for Q1 2026 at Aurinia Pharmaceuticals, down from $5.1 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $5.1 million in Q4 2025 and bottomed at -$9.2 million in Q2 2025.
- A 5-year average of -$724588.2 and a median of -$279000.0 in 2026 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2024 — Other Operating Expenses surged 1522.41% — and 2025, when it slumped 3288.28%.
- Aurinia Pharmaceuticals' Other Operating Expenses stood at $2.2 million in 2022, then plunged by 518.16% to -$9.1 million in 2023, then jumped by 149.66% to $4.5 million in 2024, then rose by 12.61% to $5.1 million in 2025, then slumped by 105.5% to -$279000.0 in 2026.
- Business Quant data shows AUPH's Other Operating Expenses at -$279000.0 in Q1 2026, $5.1 million in Q4 2025, and -$929000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Aurinia Pharmaceuticals | 2.02 Bn | 1.64 Bn | 71.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -279,000.00 |
| Dec 31, 2025 | 5.07 Mn |
| Sep 30, 2025 | -929,000.00 |
| Jun 30, 2025 | -9.25 Mn |
| Mar 31, 2025 | -4.43 Mn |
| Dec 31, 2024 | 4.51 Mn |
| Sep 30, 2024 | -4.57 Mn |
| Jun 30, 2024 | 290,000.00 |
| Mar 31, 2024 | 4.13 Mn |
| Dec 31, 2023 | -9.07 Mn |
| Sep 30, 2023 | -2.65 Mn |
| Jun 30, 2023 | 3.63 Mn |
| Mar 31, 2023 | -290,000.00 |
| Dec 31, 2022 | 2.17 Mn |
| Sep 30, 2022 | 311,000.00 |
| Jun 30, 2022 | 476,000.00 |
| Mar 31, 2022 | -1.43 Mn |
| Dec 31, 2021 | 285,000.00 |
| Sep 30, 2021 | -55,000.00 |
| Jun 30, 2021 | 967,000.00 |